FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18530711000001104: Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Mar 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63628601000001113 Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94099901000001114 Nastrosa 1mg tablets (Discovery Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Is a Product containing precisely anastrozole 1 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has active ingredient Anastrozole false Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has specific active ingredient Anastrozole true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Is a Nastrosa true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Nastrosa 1mg tablets (Discovery Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start